← Back to Search

Stool collection, Carbohydrate administration, Questionnaires for Inflammation

N/A
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

The purpose of the study is to find correlations between non-invasive fecal tests of intestinal inflammation and macro- and microscopic evaluation of duodenal and colonic histology, disaccharidase activity, and intestinal permeability in children with autism.

Eligible Conditions
  • Inflammation
  • Autism Spectrum Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

1Treatment groups
Experimental Treatment
Group I: Stool collection, Carbohydrate administration, QuestionnairesExperimental Treatment3 Interventions
A stool sample will be obtained A carbohydrate solution (lactulose plus rhamnose dissolved in tap water) will be administered during a clinically indicated endoscopic procedure. Five questionnaires will be completed by parent/guardian

Find a Location

Who is running the clinical trial?

Autism SpeaksOTHER
35 Previous Clinical Trials
3,713 Total Patients Enrolled
Massachusetts General HospitalLead Sponsor
2,932 Previous Clinical Trials
13,198,380 Total Patients Enrolled
27 Trials studying Inflammation
2,147 Patients Enrolled for Inflammation
Timothy M Buie, M.D.Study DirectorMassachusetts General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Apr 2025